A major mechanism of action of artemisinin and its derivatives against cancer cells is the induction of apoptosis, which leads to activation of caspase-3 by elevating the expression of the Bax/BCl2 ratio and inducing the release of cytochrome c from mitochondria [20,74]. This evidence concerns the gene BCL2 and cancer.